clinical trials

May 30, 2015 · Amber Bauer, ASCO staff
This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer. Read More >>
May 29, 2015 · Amber Bauer, ASCO staff
Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers. Read More >>
May 14, 2015 · Amber Bauer, ASCO staff
A recent study shows that people who took a form of vitamin B3 called nicotinamide developed fewer non-melanoma skin cancers. In this podcast, Patricia A. Ganz, MD, discusses this study and what it means for people at risk for skin cancer. Read More >>
May 5, 2015 · Cat Snyder, ASCO staff
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer. Read More >>
April 28, 2015 · Cat Snyder, ASCO staff
Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer. Read More >>

Pages